DPAM
GILD icon

Degroof Petercam Asset Management’s Gilead Sciences GILD Stock Holding History

Degroof Petercam Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$16.1M Sell
220,300
-61,500
-22% -$4.73M 0.19% 93
2023
Q4 		$22.8M Buy
+281,800
New +$21.9M 0.3% 72

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Degroof Petercam Asset Management's GILD Position: Q1 2024 in Review

Degroof Petercam Asset Management reduced its Gilead Sciences (GILD) stake by 22% in Q1 2024, selling an estimated $4.73M and leaving 220,300 shares worth $16.1M. The position accounts for 0.19% of the portfolio, ranked #93.

Degroof Petercam Asset Management first reported a position in GILD in Q4 2023 and has held it in 2 quarters since. The position peaked at $22.8M in Q4 2023. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Degroof Petercam Asset Management held 220,300 shares of Gilead Sciences worth $16.1M as of Q1 2024.
  • Degroof Petercam Asset Management sold 61,500 Gilead Sciences shares in Q1 2024, an estimated $4.73M.
  • Gilead Sciences made up 0.19% of Degroof Petercam Asset Management's portfolio in Q1 2024, its #93 holding.
  • Degroof Petercam Asset Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 2 quarters since.
  • Degroof Petercam Asset Management's Gilead Sciences position peaked at $22.8M in Q4 2023.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Degroof Petercam Asset Management's 13F filing for Q1 2024, filed 13 May 2024.